Genetically engineered immune cells target cancer cells that may be responsible for leukemia relapse - News-Medical.Net

6/2/2022 12:00:00 AM2 years 11 months ago

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the disease, according to a preclinical stu…

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in … [+3650 chars]

full article...